Quest Diagnostics (DGX) Shares Outstanding (2009 - 2026)

Quest Diagnostics has disclosed Shares Outstanding across 18 years of filings, most recently posting $111.0 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $111.0 million, down 0.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $111.0 million (down 0.89% YoY), and the FY2025 annual result was $162.0 million, changed 0.0% from the prior year.
• Shares Outstanding came in at $111.0 million for Q1 2026 at Quest Diagnostics, down from $162.0 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $162.0 million in Q1 2022 to a low of $111.0 million in Q4 2022.
• The 5-year median for Shares Outstanding is $112.0 million (2023), against an average of $129.8 million.
• Across the five-year window, Shares Outstanding tumbled 31.48% in 2024 and surged 45.95% in 2025, its largest moves.
• Quest Diagnostics' Shares Outstanding stood at $111.0 million in 2022, then changed by 0.0% to $111.0 million in 2023, then changed by 0.0% to $111.0 million in 2024, then jumped by 45.95% to $162.0 million in 2025, then slumped by 31.48% to $111.0 million in 2026.
• The last three Shares Outstanding figures came in at $111.0 million (Q1 2026), $162.0 million (Q4 2025), and $111.0 million (Q3 2025), per Business Quant data.